Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndrome
- 4 February 2019
- journal article
- conference paper
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 9 (6) , 681-687
Abstract
Background: Empty nose syndrome (ENS) is a debilitating condition associated with inferior turbinate tissue loss. Surgical augmentation of the inferior meatus has been proposed to treat ENS, although efficacy data with validated, disease‐specific questionnaires is limited. Instead we evaluated submucosal injection of a transient, resorbable filler into the inferior meatus to favorably alter nasal aerodynamics in ENS patients.Methods: Patients with a history of inferior turbinate reduction, diagnosed with ENS via Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q) and cotton testing, were enrolled and underwent submucosal injection of carboxymethylcellulose/glycerin gel (Prolaryn®) into the inferior meatuses between July 2014 and May 2018. This material likely resorbs over several months. Outcomes included comparisons of preinjection and postinjection symptoms at 1 week, 1 month, and 3 months using the ENS6Q, 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐item scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Results: Fourteen patients underwent injections. Mean ENS6Q scores significantly decreased from baseline at 1 week (20.8 vs 10.5; p < 0.0001), and remained reduced but upward‐trending at 1 month (13.7, p = 0.002) and 3 months (15.5, p > 0.05) following injections. Mean SNOT‐22 scores significantly decreased at 1 week (p = 0.01) and 1 month (p = 0.04), mean GAD‐7 at 1 month (p = 0.02) and 3 months (p = 0.02), and mean PHQ‐9 at 1 week (p = 0.01) and 1 month (p = 0.004) postinjection.Conclusion: Transient, focal airway bulking via submucosal filler injection at sites of inferior turbinate tissue loss markedly benefits ENS patients, suggesting that aberrant nasal aerodynamics from inferior turbinate tissue loss contributes to (potentially reversible) ENS symptoms.Keywords
This publication has 21 references indexed in Scilit:
- Efficacy and Safety of Autologous Stromal Vascular Fraction in the Treatment of Empty Nose SyndromeClinical and Experimental Otorhinolaryngology, 2018
- Assessment of postsurgical outcomes between different implants in patients with empty nose syndrome: A meta-analysisJournal of International Medical Research, 2017
- Surgical outcome for empty nose syndrome: Impact of implantation siteThe Laryngoscope, 2017
- The expansion of autologous adipose-derived stem cells in vitro for the functional reconstruction of nasal mucosal tissueCell & Bioscience, 2015
- Inferior turbinate reconstruction using porcine small intestine submucosal xenograft demonstrates improved quality of life outcomes in patients with empty nose syndromeInternational Forum of Allergy & Rhinology, 2015
- Pathophysiology of empty nose syndromeThe Laryngoscope, 2014
- Costal Cartilage Is a Superior Implant Material than Conchal Cartilage in the Treatment of Empty Nose SyndromeOtolaryngology–Head and Neck Surgery, 2013
- Empty nose syndromeEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2012
- Hyaluronic Acid Gel in the Treatment of Empty Nose SyndromeAmerican Journal of Rhinology & Allergy, 2011
- Surgical Treatment for Empty Nose SyndromeJAMA Otolaryngology–Head & Neck Surgery, 2007